Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Rise of Generics and Patent Expirations Sees CPhI and P-MEC India 2013 Expand

Published: Tuesday, December 03, 2013
Last Updated: Monday, December 02, 2013
Bookmark and Share
Free online registration to attend CPhI and P-MEC India is now closed.

CPhI has announced that CPhI and P-MEC India, ran by leading events organizer UBM, is returning to the Bombay Convention and Exhibition Centre, Mumbai (India) from the 3rd to the 5th December 2013.

The event will return with an increased scale, continuing its commitment to cater to all sectors of the pharma industry by co-locating with ICSE and BioPh India.

With a view to enhancing the customer experience and ROI value, CPhI India has enhanced the mobile application, now available on all mobile devices with an internet connection, designed to help attendees navigate their way around the event, drive traffic to stands and stay up to date with schedules and speaker events.

With the addition of hall 7, P-MEC will host even more exhibitors than previous years. Last year, there were 926 exhibitors present and this is expected to rise to 1,000 this year to create the biggest show to date.

Free online registration to attend CPhI and P-MEC India is now closed, however registration is still possible in Mumbai, the onsite fee is only INR500.

India has increasingly become a focal point of the pharmaceutical industry and is now the third largest in terms of volume. The country is fast becoming an innovation hub, increasingly matching Western standards, whilst also reducing the costs of manufacturing, showcasing the Indian pharma markets unique position and providing an optimum investment platform for international companies.

Outside of the US, India has the highest number of FDA approved facilities (546), and the Indian pharma sector received USFDA approvals for around 40% of all Abbreviated New Drug Approvals (ANDA) during January-July 2013.

Further, with R&D investments rapidly advancing, coupled with the rise in generics and supergenerics, India represents a key maturing market, with CPhI and P-MEC India facilitating opportunities to drive and enhance the sector.

Ahead of the event, the UBM India pharma awards will take place on 2nd December, celebrating the most innovative and dynamic areas across the Indian pharma community.

Honouring companies who are driving forward industry changing initiatives, there will be awards for multiple categories including ‘Excellence in Product Development’, ‘Excellence in Contract Research’ and ‘Excellence in Packaging Development’.

The evening will also host a panel discussion on ‘Moving up the Global Pharma Value Chain’, designed to inform and educate those present at the awards ceremony.

“The global pharmaceutical market has seen a significant shift over the last year, particularly as patent expirations are becoming more frequent and a potential patent cliff is shaking the industry. India, however, is thriving as the demand for generics is on the rise and companies are looking to drive down manufacturing costs. India is well positioned to accommodate increased demand, providing expertise in development and manufacturing. CPhI and P-MEC India will provide the ideal and essential platform for international and domestic suppliers and buyers to break into the market,” Chris Kilbee, Group Director, Pharma.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

CPhI Worldwide Launches Pharma Insights 2016 USA Report at InformEx 2016
CPhI report warns international manufacturers about the need to invest in domestic US sites and indicates that US CDMOs are well placed to keep biosimilars development work into commercialisation.
Friday, February 05, 2016
CPhI Worldwide Closes with Growth Forecast in FDI and Latin American Exports
Event sees record exhibitor attendance and is set to return to thriving Spain in 2016.
Friday, December 18, 2015
CPhI Report Highlights Acquisitions of Niche Technologies
Medium term prospects for contract services remain positive (both developed and emerging markets), despite fragmented biosimilar regulation and GDUFA fees.
Thursday, October 15, 2015
#CPhIChat Returns to CPhI Worldwide for the Second Successive Year
Pharma community is encouraged to lend their views on key industry issues.
Saturday, October 10, 2015
CPhI Experts Predict Continuous Manufacturing for All Within 10-years
Brian Carlin emphasizes need to build flexibility into design to manage impact of raw material variability through product lifecycle.
Thursday, October 01, 2015
CPhI China Report Predicts Domestic Growth to Outpace Exports
Emerging cities, biopharmaceuticals and APIs to drive future expansion.
Friday, August 14, 2015
CPhI & P-MEC China Closes as the Chinese Domestic Market Continues to Expand
International companies looking to gain a foothold in this lucrative and gentrifying pharma economy.
Tuesday, August 11, 2015
CPhI Korea Opens as South Korea Emerges as Global Leader in Biosimilar Trials
Government’s R&D strategy and “Pharma 2020 Vision” to see country as drug development leader.
Monday, July 27, 2015
CPhI Announces USA Market Report at InformEx
Country report to contain contrasting insights into the American pharma economy from European and domestic perspectives.
Wednesday, January 22, 2014
Chris Kilbee Appointed Group Director of UBM Pharma Portfolio
Kilbee responsible for driving the portfolio globally including increased emphasis on digital and content.
Monday, January 13, 2014
CPhI Japan 2014: Japanese Market to Continue to Dominate Global Pharma
Growth in the World’s second largest pharma region facilitated by innovation and loosened regulatory guidelines.
Monday, December 30, 2013
John van der Valk Appointed MD of UBM Live Amsterdam
Valk responsible for overseeing the company’s flagship brand CPhI.
Monday, December 23, 2013
CPhI Worldwide 2013 Hosted More Than 34,000 Global Pharma Professionals
This year sees strong growth in APIs, biopharma, natural extracts, packaging and finished dosage with a highlight on innovation.
Tuesday, November 26, 2013
India Sets Ambitious Pharma Export Growth Targets
Indian generics exports growing at 24% per annum.
Monday, October 21, 2013
Scientific News
Breaking Cell Barriers with Retractable Protein Nanoneedles
Adapting a bacterial structure, institute researchers have developed protein actuators that can mechanically puncture cells.
Gene Signature could Lead to a New Way of Diagnosing Lyme Disease
Lyme disease patients had distinctive gene signatures that persisted for at least three weeks, even after they had taken the antibiotics.
Retractable Protein Nanoneedles
The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.
Leukemia’s Surroundings Key to its Growth
Researchers at The University of Texas at Austin have discovered that a type of cancer found primarily in children can grow only when signaled to do so by other nearby cells that are noncancerous.
Common Cell Transformed into Master Heart Cell
By genetically reprogramming the most common type of cell in mammalian connective tissue, researchers at the University of Wisconsin—Madison have generated master heart cells — primitive progenitors that form the developing heart.
‘Smelling’ Prostate Cancer
A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.
Genetic Mutation that Prevents Diabetes Complications
The most significant complications of diabetes include diabetic retinal disease, or retinopathy, and diabetic kidney disease, or nephropathy. Both involve damaged capillaries.
A Crystal Clear View of Biomolecules
Fundamental discovery triggers paradigm shift in crystallography.
Could the Food we Eat Affect Our Genes?
Almost all of our genes may be influenced by the food we eat, according to new research.
NIH Seeks Research Applications to Study Zika in Pregnancy, Developing Fetus
Institute has announced that the new effort seeks to understand virus effect on reproduction and child development.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!